Beijing Scitop Bio Tech Co Ltd Tangible Net Worth Ratio
Beijing Scitop Bio Tech Co Ltd tangible net worth ratio. Beijing Scitop Bio Tech Co Ltd (300858) has a Tangible Net Worth Ratio of 96.7% as of June 2026. This metric is calculated by deducting intangible assets (CN¥58.78 Million) from net assets (CN¥1.79 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Beijing Scitop Bio Tech Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Beijing Scitop Bio Tech Co Ltd (2015–2025)
Tangible net worth ratio of Beijing Scitop Bio Tech Co Ltd from 2015 to 2025. This chart shows how Beijing Scitop Bio Tech Co Ltd's Tangible Net Worth Ratio has changed across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 96.7%, reflecting net assets of CN¥1.79 Billion with intangible assets of CN¥58.78 Million CNY. Check 300858 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Beijing Scitop Bio Tech Co Ltd Tangible Net Worth Ratio by Year (2015–2025)
Beijing Scitop Bio Tech Co Ltd tangible net worth ratio by year from 2015 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Beijing Scitop Bio Tech Co Ltd from 2015 to 2025, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Beijing Scitop Bio Tech Co Ltd market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.7% | CN¥1.84 Billion | CN¥60.10 Million | CN¥2.02 Billion | ▼ -0.6 pp |
| 2024 | 97.3% | CN¥1.79 Billion | CN¥48.33 Million | CN¥1.92 Billion | ▲ +0.2 pp |
| 2023 | 97.1% | CN¥1.73 Billion | CN¥51.06 Million | CN¥1.81 Billion | ▲ +0.2 pp |
| 2022 | 96.9% | CN¥1.70 Billion | CN¥53.05 Million | CN¥1.79 Billion | ▲ +2.5 pp |
| 2021 | 94.4% | CN¥967.40 Million | CN¥54.16 Million | CN¥1.04 Billion | ▼ -3.6 pp |
| 2020 | 98.0% | CN¥932.59 Million | CN¥18.82 Million | CN¥999.25 Million | ▲ +3.1 pp |
| 2019 | 94.9% | CN¥399.83 Million | CN¥20.57 Million | CN¥465.97 Million | ▲ +1.1 pp |
| 2018 | 93.8% | CN¥301.83 Million | CN¥18.82 Million | CN¥373.74 Million | ▲ +1.1 pp |
| 2017 | 92.7% | CN¥281.09 Million | CN¥20.61 Million | CN¥337.39 Million | ▲ +4.2 pp |
| 2016 | 88.5% | CN¥194.57 Million | CN¥22.38 Million | CN¥266.26 Million | ▲ +7.9 pp |
| 2015 | 80.5% | CN¥52.67 Million | CN¥10.24 Million | CN¥184.55 Million | — |